ArticleBeyond PARP – What’s Next For DNA Damage Response-targeted Therapies?29 June 2026United Kingdom · Intellectual Property
ArticleUPC Court Of Appeal Endorses EPO Approach To Inventive Step For Computer-Implemented Inventions12 May 2026United Kingdom · Intellectual Property
ArticleHow The EU Is Re-Shaping The Regulation Of Gene-Edited Plants30 March 2026European Union · Intellectual Property
ArticleUKIPO To Increase Official Fees From 1 April 202606 March 2026United Kingdom · Intellectual Property
ArticleRequesting Patent Prosecution Highway (PPH) In The EPO Or UK IPO04 February 2026United Kingdom · Intellectual Property
ArticleRecourse To The Prosecution History In The UK12 January 2026United Kingdom · Intellectual Property
ArticleEU Reaches Provisional Agreement On Reform For Regulatory Exclusivity Periods For Pharma Products18 December 2025European Union · Intellectual Property
ArticleClimate Resilient Crops – Mitigating The Risks Of Climate Change27 November 2025United Kingdom · Environment
ArticleUPC Court Of Appeal And UK Supreme Court Concur On High Threshold For Director Liability17 October 2025United Kingdom · Intellectual Property
ArticleThe Price Of Non-payment: CJEU Upholds Cancellation Of Plant Variety Right03 September 2025European Union · Intellectual Property
ArticleUPC Court Of Appeal Sets A High Bar For Suspending Enforcement Of First Instance Orders Pending Appeal10 July 2025United Kingdom · Intellectual Property
ArticleUPC Milan Local Division Grants Stay In Proceedings Pending Adaptation Of Description At EPO10 July 2025United Kingdom · Intellectual Property
ArticleUPC Court Of Appeal Confirms Competence To Decide On Pre-UPCA Infringing Acts And Infringing Acts Performed While An Opt-out Was In Place10 June 2025United Kingdom · Intellectual Property
ArticleUPC Holds That A Patent Is Infringed By Way Of Equivalence05 December 2024United Kingdom · Intellectual Property
ArticleNew Referral To The EPO Enlarged Board Of Appeal Regarding The Status Of An Intervener – G 2/2429 November 2024United Kingdom · Intellectual Property
ArticleTeva Fined €462.6 Million By European Commission For Abusing EPO's Patent System28 November 2024United Kingdom · Intellectual Property
VideoJ A Kemp & DLRC Joint Webinar | Optimising Patent Strategies Under The Revised EU Clinical Trials Transparency Rules (Video)26 November 2024United Kingdom · Intellectual Property
VideoDrafting And Prosecuting Applications For Polymorphs Of Drug Compounds At The EPO (Video)26 November 2024United Kingdom · Intellectual Property